News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
21-Jan-2005 - Cambrex Corporation announced that its subsidiary Cambrex Bio Science Wokingham, Ltd. has signed an agreement for the purchase of conditionally immortalized cell lines, related intellectual property and equipment of Xcellsyz Limited, Newcastle Upon Tyne, United Kingdom. Cambrex Bio Science ...
20-Jan-2005 - Amylin Pharmaceuticals, Inc. announced that it has filed a preliminary prospectus supplement to its shelf registration statement with the Securities and Exchange Commission relating to a proposed underwritten public offering of 6.5 million shares of its common stock. To the extent that the ...
20-Jan-2005 - DOR BioPharma, Inc. and a subsidiary of Cambrex Corporation have entered into an agreement with respect to process development for potential large scale production of DOR's proprietary ricin vaccine, RiVax(TM). Under the agreement, Cambrex will provide process development and cGMP (current Good ...
20-Jan-2005 - BioFine 2005, the international life science exhibition and networking event, takes place in Berlin, Germany from April 13-14, 2005, and already more than 60 exhibiting companies have confirmed their participation in the event. Organised by avakado, publisher of sp2 magazine, BioFine 2005 is the ...
20-Jan-2005 - PPD, Inc. and SurroMed, Inc. announced they have entered into an agreement for PPD to acquire substantially all of SurroMed's assets related to its biomarker business. Under the terms of the agreement, in exchange for the assets of SurroMed's biomarker business, PPD will surrender for ...
19-Jan-2005 - Shire Pharmaceuticals Group plc announced that it has out-licensed its HIV compound, SPD754, to Avexa Limited, a publicly-listed Australian specialty anti-infectives company. This is one of the final steps in Shire's divestment program - designed to ensure focus on later stage pipeline ...
18-Jan-2005 - Aceto Corporation announced that it signed an agreement with Three Rivers Pharmaceuticals, LLC to bring three generic biopharmaceutical products to market. Under the agreement, Aceto will source the active pharmaceutical ingredients, manage the regulatory and quality control functions of ...
18-Jan-2005 - Corgenix Medical Corporation announced that due to the lack of progress towards the completion of the $6 million merger-related financing and the expiration of key dates within the Agreement and Plan of Merger, it has decided to terminate the planned merger with Genesis Bioventures, Inc.
Strategic Analysis of the World Plant Molecular Farming Market
18-Jan-2005 - New analysis from Frost & Sullivan, Strategic Analysis of the World Plant Molecular Farming Market, reveals that the biopharmaceutical market generated revenues of USD 45.0 billion in 2004. It is likely to reach USD 98.2 billion by 2011. Despite this soaring demand for biopharmaceuticals, little ...
Botulism Ranks in CDC's Category "A" Threat List for Bioweapons
18-Jan-2005 - Emergent BioSolutions and the British-based Health Protection Agency (HPA) announced a two-year collaboration for the development of vaccines to prevent botulism. These two leaders in biodefense vaccines have long-established capabilities in the prevention of botulism dating to the 1950s. In a ...
© 1997-2024 LUMITOS AG, All rights reserved